Aldeyra Therapeutics (NASDAQ:ALDX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Aldeyra Therapeutics (ALDX) operate in?

Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Aldeyra Therapeutics Stock (NASDAQ: ALDX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 393.43K
Day Range	- - -
52 Wk Range	2.71 - 6.92
Market Cap	$399.58M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	73
Short Interest	7.42%
Days to Cover	12.14

Recent News

Aldeyra's New Eye Drug Shows Positive Results In FDA-Approved Study, Stock Jumps Over 30%

Aldeyra Therapeutics announces successful results from its Phase 3 clinical trial of reproxalap. The results support a potential 2024 NDA resubmission.

Vandana Singh

Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Positive News For Skin Health: Aldeyra Therapeutics' ADX-629 Achieves Key Milestones in Atopic Dermatitis Study

Aldeyra Therapeutics Inc (NASDAQ: ALDX) released topline results from a Phase 2 clinical trial of ADX-629, an investigational RASP modulator, in

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 393.43K
Day Range	- - -
52 Wk Range	2.71 - 6.92
Market Cap	$399.58M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	73
Short Interest	7.42%
Days to Cover	12.14

About Aldeyra Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-g...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aldeyra Therapeutics (ALDX) stock?

You can purchase shares of Aldeyra Therapeutics (NASDAQ:ALDX) through any online brokerage.

View our list of the best stock brokerages

Who are Aldeyra Therapeutics (ALDX) competitors?

Other companies in Aldeyra Therapeutics’s space includes: Upstream Bio (NASDAQ:UPB), Sage Therapeutics (NASDAQ:SAGE), aTyr Pharma (NASDAQ:ATYR), PureTech Health (NASDAQ:PRTC) and Monte Rosa Therapeutics (NASDAQ:GLUE).

What is the forecast, or price target, for Aldeyra Therapeutics (ALDX) stock?

Aldeyra Therapeutics has a consensus price target of $10.75.

What is the current price for Aldeyra Therapeutics (ALDX)?

The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $6.71 last updated February 20, 2025 at 7:43 PM EST.

Does Aldeyra Therapeutics (ALDX) pay a dividend?

There are no upcoming dividends for Aldeyra Therapeutics.

When is Aldeyra Therapeutics (NASDAQ:ALDX) reporting earnings?

Aldeyra Therapeutics’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Aldeyra Therapeutics (ALDX) going to split?

There is no upcoming split for Aldeyra Therapeutics.

What sector and industry does Aldeyra Therapeutics (ALDX) operate in?

Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Aldeyra Therapeutics

Aldeyra Therapeutics (ALDX) Forecast